European Society for Neurogastroenterology and Motility recommendations for conducting gastrointestinal motility and function testing in the recovery phase of the COVID-19 pandemic.
Betacoronavirus
COVID-19
Coronavirus Infections
/ diagnosis
Europe
/ epidemiology
Expert Testimony
/ methods
Gastroenterology
/ standards
Gastrointestinal Motility
/ physiology
Health Personnel
/ standards
Humans
Neurology
/ standards
Pandemics
/ prevention & control
Pneumonia, Viral
/ diagnosis
Practice Guidelines as Topic
/ standards
Protective Clothing
/ standards
Recovery of Function
/ physiology
SARS-CoV-2
Societies, Medical
/ standards
COVID-19
breath test
esophageal manometry
pH monitoring
personal protection equipment
Journal
Neurogastroenterology and motility
ISSN: 1365-2982
Titre abrégé: Neurogastroenterol Motil
Pays: England
ID NLM: 9432572
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
received:
04
06
2020
revised:
06
06
2020
accepted:
08
06
2020
pubmed:
12
6
2020
medline:
11
7
2020
entrez:
12
6
2020
Statut:
ppublish
Résumé
During the peak of the COronaVIrus Disease 2019 (COVID-19) pandemic, care for patients with gastrointestinal motility and functional disorders was largely suspended. In the recovery phases of the pandemic, non-urgent medical care is resumed, but there is a lack of guidance for restarting and safely conducting motility and function testing. Breath tests and insertion of manometry and pH-monitoring probes carry a risk of SARS-CoV-2 spread through droplet formation. A panel of experts from the European Society for Neurogastroenterology and Motility (ESNM) evaluated emerging national and single-center recommendations to provide the best current evidence and a pragmatic approach to ensure the safe conduct of motility and function testing for both healthcare professionals and patients. At a general level, this involves evaluation of the urgency of the procedure, evaluation of the infectious risk associated with the patient, the investigation and the healthcare professional(s) involved, provision of the test planning and test units, education and training of staff, and use of personnel protection equipment. Additional guidance is provided for specific procedures such as esophageal manometry, pH monitoring, and breath tests. The ESNM guidelines provide pragmatic and appropriate guidance for the safe conduct of motility and function testing in the COVID-19 pandemic and early recovery phase.
Sections du résumé
BACKGROUND
During the peak of the COronaVIrus Disease 2019 (COVID-19) pandemic, care for patients with gastrointestinal motility and functional disorders was largely suspended. In the recovery phases of the pandemic, non-urgent medical care is resumed, but there is a lack of guidance for restarting and safely conducting motility and function testing. Breath tests and insertion of manometry and pH-monitoring probes carry a risk of SARS-CoV-2 spread through droplet formation.
METHODS
A panel of experts from the European Society for Neurogastroenterology and Motility (ESNM) evaluated emerging national and single-center recommendations to provide the best current evidence and a pragmatic approach to ensure the safe conduct of motility and function testing for both healthcare professionals and patients.
RESULTS
At a general level, this involves evaluation of the urgency of the procedure, evaluation of the infectious risk associated with the patient, the investigation and the healthcare professional(s) involved, provision of the test planning and test units, education and training of staff, and use of personnel protection equipment. Additional guidance is provided for specific procedures such as esophageal manometry, pH monitoring, and breath tests.
CONCLUSIONS AND INFERENCES
The ESNM guidelines provide pragmatic and appropriate guidance for the safe conduct of motility and function testing in the COVID-19 pandemic and early recovery phase.
Identifiants
pubmed: 32525249
doi: 10.1111/nmo.13930
pmc: PMC7300574
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13930Investigateurs
Fernando Azpiroz
(F)
Serhat Bor
(S)
Ram Dickman
(R)
Asbjørn Drewes
(A)
Vasile Drug
(V)
Paul Enck
(P)
Adam Farmer
(A)
Goran Hauser
(G)
Agata Mulak
(A)
Luis Novais
(L)
Daniel Pohl
(D)
Edoardo Savarino
(E)
Olga Storonova
(O)
Frank Zerbib
(F)
Florencia Carbone
(F)
Annelies Geeraerts
(A)
Jolien Schol
(J)
Annamaria Altomare
(A)
Fabio Baldi
(F)
Massimo Bellini
(M)
Giovanni Cataudella
(G)
Mario Costantini
(M)
Cesare Cremon
(C)
Domenico Della Casa
(DD)
Paola Iovino
(P)
Claudio Londoni
(C)
Elisa Marabotto
(E)
Renato Salvador
(R)
Salvatore Tolone
(S)
Javier Alcedo
(J)
Julio Pérez de la Serna
(J)
Pilar Mas
(P)
Elisabeth Barba
(E)
José F Suárez
(JF)
Antonio Ruiz de León
(A)
Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2020 John Wiley & Sons Ltd.
Références
J Clin Virol. 2020 Jun;127:104346
pubmed: 32361324
Influenza Other Respir Viruses. 2020 Jul;14(4):365-373
pubmed: 32246890
Gut. 2020 Aug;69(8):1547-1548
pubmed: 32409587
Am J Gastroenterol. 2020 Jun;115(6):942-946
pubmed: 32496741
United European Gastroenterol J. 2020 Jun;8(5):520-527
pubmed: 32281517
Gut. 2020 Nov;69(11):1925-1927
pubmed: 32321857
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):629-630
pubmed: 32405602
Neurogastroenterol Motil. 2020 Jul;32(7):e13930
pubmed: 32525249
Clin Infect Dis. 2020 Nov 19;71(16):2132-2138
pubmed: 32442265
Infect Dis Poverty. 2020 Apr 28;9(1):45
pubmed: 32345362
Gastroenterology. 2016 Feb 15;:
pubmed: 27144625
Emerg Microbes Infect. 2020 Dec;9(1):747-756
pubmed: 32196430
Gastroenterology. 2021 Jan;160(1):99-114.e3
pubmed: 32294476
Clin Microbiol Infect. 2020 Jul;26(7):948.e1-948.e3
pubmed: 32360780
Nat Rev Gastroenterol Hepatol. 2018 May;15(5):323
pubmed: 29622813
Clin Infect Dis. 2020 Nov 19;71(16):2249-2251
pubmed: 32306036
Lancet Infect Dis. 2020 Sep;20(9):1010-1011
pubmed: 32222164
Best Pract Res Clin Gastroenterol. 2007;21(3):379-91
pubmed: 17544106
Am J Gastroenterol. 2020 Oct;115(10):1575-1583
pubmed: 32868631
Emerg Infect Dis. 2020 Jul;26(7):
pubmed: 32364890
Nat Rev Gastroenterol Hepatol. 2016 May;13(5):281-94
pubmed: 27075264
J Infect Public Health. 2020 May;13(5):667-673
pubmed: 32340833
Gastroenterol Hepatol. 2020 Oct;43(8):485-496
pubmed: 32680731
Endoscopy. 2020 Jun;52(6):483-490
pubmed: 32303090
Nat Rev Gastroenterol Hepatol. 2018 May;15(5):291-308
pubmed: 29622808
JAMA. 2020 May 19;323(19):1881-1883
pubmed: 32301958
Emerg Microbes Infect. 2020 Dec;9(1):787-793
pubmed: 32241244
Dig Endosc. 2020 Jul;32(5):723-731
pubmed: 32335962
AJR Am J Roentgenol. 2020 Oct;215(4):839-842
pubmed: 32298149
Crit Care. 2020 Mar 27;24(1):120
pubmed: 32220243
J Gastrointest Surg. 2020 Feb;24(2):411-417
pubmed: 30825120
Neurogastroenterol Motil. 2021 May;33(5):e14043
pubmed: 33274525
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):667-678
pubmed: 32405603
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
J Autoimmun. 2020 May;109:102433
pubmed: 32113704
Neurogastroenterol Motil. 2008 May;20 Suppl 1:121-9
pubmed: 18402649
Gastrointest Endosc. 2020 Sep;92(3):524-534.e6
pubmed: 32360302
Neurogastroenterol Motil. 2020 Jan;32(1):e13679
pubmed: 31407463
Aliment Pharmacol Ther. 2020 May;51(9):843-851
pubmed: 32222988
Neurogastroenterol Motil. 2020 Jul;32(7):e13926
pubmed: 32478910
Gastroenterology. 2016 May;150(6):1257-61
pubmed: 27147121